Literature DB >> 20455859

Low levels of high density lipoprotein increase the severity of cerebral white matter changes: implications for prevention and treatment of cerebrovascular diseases.

M Crisby1, L Bronge, L-O Wahlund.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral White matter changes (WMC) are a frequent finding on CT and MRI scans of elderly individuals, particularly in those with vascular risk factors, cerberovascular disease, and cognitive impairment.
METHODS: 56 subjects were included in the study after the review of reports of more than 200 consecutive brain Computerized Tomography (CT) and magnetic resonance imaging (MRI) examinations from the out-patient and in-patient units of the Department of Geriatric Medicine at Karolinska University Hospital, Huddinge during 2001-2002. MRI was performed using a 1.5 T system and WMC lesions were graded 1-3 using a visual scale. Total-cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL) and triglyceride (TG) levels were determined using enzymatic techniques after 12 hours overnight fasting. Apo E genotyping was performed as described.
RESULTS: Low HDL levels were associated with higher severity of WMC on MRI (p=0.002). Subjects with the Apo E4 allele had higher LDL (p=0.02) and apoB levels (p=0.005). The presence of the Apo E4 allele was higher in the group of subjects with severe WMC (grade 3). However, there was no statistically significant group difference in severity of WMC lesions between carriers and non-carriers of Apo E4 allele.
CONCLUSIONS: Low HDL is strongly associated with adverse coronary and cerebrovascular outcomes. Our results indicate that low HDL levels are also associated with more severe WMC lesions on MRI. Dietary or medical adjustment of HDL levels could have important implications for treatment and prevention of cerebral WMC, cerebrovascular and neurodegenerative diseases such as stroke and dementia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20455859     DOI: 10.2174/156720510792231694

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  14 in total

Review 1.  APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Authors:  Sabrina Schilling; Anita L DeStefano; Perminder S Sachdev; Seung Hoan Choi; Karen A Mather; Charles D DeCarli; Wei Wen; Peter Høgh; Naftali Raz; Rhoda Au; Alexa Beiser; Philip A Wolf; José Rafael Romero; Yi-Cheng Zhu; Kathryn L Lunetta; Lindsay Farrer; Carole Dufouil; Lewis H Kuller; Bernard Mazoyer; Sudha Seshadri; Christophe Tzourio; Stéphanie Debette
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

2.  Lipids and adipokines as risk factors for Alzheimer's disease.

Authors:  Matthew W Warren; Linda S Hynan; Myron F Weiner
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Hyperinsulinemia and elevated systolic blood pressure independently predict white matter hyperintensities with associated cognitive decrement in the middle-aged offspring of dementia patients.

Authors:  Keith A Hawkins; Nazli Emadi; Godfrey D Pearlson; Anderson M Winkler; Beth Taylor; Latha Dulipsingh; Diana King; Brian Pittman; Karen Blank
Journal:  Metab Brain Dis       Date:  2017-03-03       Impact factor: 3.584

4.  Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.

Authors:  Latisha Love-Gregory; Richard Sherva; Timothy Schappe; Jian-Shen Qi; Jennifer McCrea; Samuel Klein; Margery A Connelly; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2010-10-08       Impact factor: 6.150

5.  ABCA1/ApoE/HDL Pathway Mediates GW3965-Induced Neurorestoration After Stroke.

Authors:  Xu Cui; Michael Chopp; Zhenggang Zhang; Rongwen Li; Alex Zacharek; Julie Landschoot-Ward; Poornima Venkat; Jieli Chen
Journal:  Stroke       Date:  2016-12-27       Impact factor: 7.914

6.  Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer's disease: the National Finnish population study (FINRISK).

Authors:  Juho Tynkkynen; Jussi A Hernesniemi; Tiina Laatikainen; Aki S Havulinna; Jouko Sundvall; Jaana Leiviskä; Perttu Salo; Veikko Salomaa
Journal:  Age (Dordr)       Date:  2016-09-23

7.  White matter changes associated with antipsychotic treatment in first-episode psychosis.

Authors:  Philip R Szeszko; Delbert G Robinson; Toshikazu Ikuta; Bart D Peters; Juan A Gallego; John Kane; Anil K Malhotra
Journal:  Neuropsychopharmacology       Date:  2013-10-16       Impact factor: 7.853

8.  D-4F Decreases White Matter Damage After Stroke in Mice.

Authors:  Xu Cui; Michael Chopp; Alex Zacharek; Chengcheng Cui; Tao Yan; Ruizhuo Ning; Jieli Chen
Journal:  Stroke       Date:  2015-11-24       Impact factor: 7.914

9.  [Correlation of apolipoprotein AI, apolipoprotein B and their ratio with the severity of cerebral white matter lesions].

Authors:  Weihua Huang; Tianming Lv; Huanmin Li; Shuhua Du; Canhong Yang; Shiqi Yuan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

10.  Relationship between orthostatic hypotension and white matter hyperintensity load in older patients with mild dementia.

Authors:  Hogne Soennesyn; Dennis W Nilsen; Ketil Oppedal; Ole Jacob Greve; Mona K Beyer; Dag Aarsland
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.